IL6 and cancer: Recently, oncogene MCT-1 was found to promote IL-6/IL-6R/STAT3 axis that leads to increased EMT process and cancer stemness but also affects the tumor immunity as seen by increased polarization of macrophages toward the immunosuppressive M2 phenotype which drive the invasiveness of breast cancer cells [86].